Patients who receive a drug - eluting stent (DES) and demonstrate high platelet reactivity on clopidogrel are more likely to have blood clots form on the stent and to suffer a heart attack; however, these patients are less likely to
develop bleeding complications.
Not exact matches
Babies in the high - risk group died or
developed serious
complications such as infections,
bleeding, and lung and heart problems.